Page last updated: 2024-09-03

cgs 22652 and 6-(4-(2-(((4-chlorophenyl)sulfonyl)amino)ethyl)phenyl)-6-(3-pyridyl)hex-5-enoic acid

cgs 22652 has been researched along with 6-(4-(2-(((4-chlorophenyl)sulfonyl)amino)ethyl)phenyl)-6-(3-pyridyl)hex-5-enoic acid in 1 studies

Compound Research Comparison

Studies
(cgs 22652)
Trials
(cgs 22652)
Recent Studies (post-2010)
(cgs 22652)
Studies
(6-(4-(2-(((4-chlorophenyl)sulfonyl)amino)ethyl)phenyl)-6-(3-pyridyl)hex-5-enoic acid)
Trials
(6-(4-(2-(((4-chlorophenyl)sulfonyl)amino)ethyl)phenyl)-6-(3-pyridyl)hex-5-enoic acid)
Recent Studies (post-2010) (6-(4-(2-(((4-chlorophenyl)sulfonyl)amino)ethyl)phenyl)-6-(3-pyridyl)hex-5-enoic acid)
1000900

Protein Interaction Comparison

ProteinTaxonomycgs 22652 (IC50)6-(4-(2-(((4-chlorophenyl)sulfonyl)amino)ethyl)phenyl)-6-(3-pyridyl)hex-5-enoic acid (IC50)
Thromboxane A2 receptor Homo sapiens (human)0.019
Thromboxane-A synthase Homo sapiens (human)0.004
Thromboxane-A synthaseRattus norvegicus (Norway rat)0.004

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eisert, W; Heckel, A; Müller, TH; Nickl, J; Soyka, R; Weisenberger, H1

Other Studies

1 other study(ies) available for cgs 22652 and 6-(4-(2-(((4-chlorophenyl)sulfonyl)amino)ethyl)phenyl)-6-(3-pyridyl)hex-5-enoic acid

ArticleYear
6,6-Disubstituted Hex-5-enoic acid derivatives as combined thromboxane A2 receptor antagonists and synthetase inhibitors.
    Journal of medicinal chemistry, 1994, Jan-07, Volume: 37, Issue:1

    Topics: Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Collagen; Drug Design; Fatty Acids, Unsaturated; Humans; Hydrazines; Molecular Conformation; Molecular Structure; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; Receptors, Thromboxane; Structure-Activity Relationship; Thromboxane A2; Thromboxane-A Synthase; Tritium

1994